Toxicogenomics: Its Role in Health Assessment and Environmental Safety

June 27, 2006

Society of Chemical Industry, SCI , 14/15 Belgrave Square, London, UK Monday 30 October 2006 The sequencing of the human genome, and those of model species used in toxicology, has driven the development of new technologies that allow the effects of chemicals on biological systems to be characterised rapidly and holistically. Among these technologies is toxicogenomics, which measures changes in gene expression in response to chemical exposure at a genome-wide level. The judicious use of toxicogenomics is expected to enhance and accelerate the safety assessment of new chemicals. The aim of this meeting is to (1) communicate and discuss the opportunities for the application of toxicogenomics to health assessment and environment safety, and (2) to identify the areas in which toxicogenomics can be expected to have the greatest impact during the next 5-10 years.

Organized by:			Society of Chemical Industry (SCI)
Invited Speakers:			Jonathan Moggs (Syngenta, CTL);Alan Boobis (Imperial College); Tim Gant (MRC Toxicology Unit, Leicester); George Orphanides (Syngenta, CTL); Jason Snape (AstraZeneca, Brixham); Lesley Onyon The International Programme on Chemical Safety/Organisation for Economic Co-operation and Development (IPCS/OECD);

Deadline for Abstracts:			Monday 14 August 2006

Registration:			To register, or for further information please go to www.soci.org
E-mail:			nicole_honeyghan@soci.org

events